Pelvic Infection: Clinical Trials

5 trials for Pelvic Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 unknown. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Recruiting 1, Unknown 1
Phase 11Recruiting 1

Follow Pelvic Infection: new trials by email Literature Review of Pelvic Infection trials Research Report on Pelvic Infection

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain
Custom-formulated, high-CBD study product, Placebo - Endometriosis, Adenomyosis
Phase 1 / Phase 2RecruitingStaci Gruber, Ph.D.602026-09-012026-07-27
Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases
Control Group, Test Group - Pelvic Inflammatory Disease
Phase 2CompletedUniversity of Karachi1982021-09-212023-04-04
Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae
Comprehensive treatment of TCM, Expectant treatment - Pelvic Inflammatory Disease
Phase 2UnknownShanghai University of Traditional Chinese Medicine1752016-11-012016-11-23
The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
Ceftriaxone, Doxycycline, Metronidazole - Pelvic Inflammatory Disease
Phase 2CompletedHarold Wiesenfeld2332010-11-012018-07-10
An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)
MK0826, ertapenem sodium, Comparator: Ticarcillin/Clavulanate - Infections, Pelvic Infections
Phase 2CompletedMerck Sharp & Dohme LLC1002002-03-012017-02-17

Narrower conditions

Pelvic Inflammatory Disease (4)  ·  Adenomyosis (1)  ·  Endometriosis (1)  ·  Infections (1)  ·  Intraabdominal Infections (1)

Broader conditions

Adnexal Diseases (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genital Diseases (4)  ·  Genital Diseases, Female (4)  ·  Infections (4)  ·  Urogenital Diseases (4)  ·  Uterine Diseases (1)

Interventions

Ceftriaxone (1)  ·  Clavulanic Acid (1)  ·  Control Groups (1)  ·  Doxycycline (1)  ·  Ertapenem (1)  ·  Medicine, Chinese Traditional (1)  ·  Metronidazole (1)  ·  Oral Medicine (1)

Sponsors

Harold Wiesenfeld (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Shanghai University of Traditional Chinese Medicine (1)  ·  Staci Gruber, Ph.D. (1)  ·  University of Karachi (1)

Countries

United States (2)  ·  China (1)  ·  Pakistan (1)

Top investigators

Harold C Wiesenfeld, MD (1)  ·  Professor Dr. Muhammad Raza Shah (1)

Results publications

PMID 32052831, PMID 38584600

NIH funding

U19AI084024 (1)